74.51000 USD
0.64
0.85%
Last update Dec 15, 3:59 PM EST
Post-market
Day range
73.95000
75.61000
Previous close
75.15000
Open
74.98000
Access this stock data via API
Subscribe
BridgeBio Pharma Inc.
74.51
0.64
0.85%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 120.7M 110.6M 116.6M 5.9M
Cost of revenue 6.6M 3.7M 2.6M 2.1M
Gross profit 114.1M 106.9M 114.0M 3.8M
Operating expense
Research & development 112.9M 111.2M 111.4M 130.4M
Selling general and admin 137.6M 129.2M 106.4M 94.8M
Other operating expenses
Operating income -136.4M -133.5M -103.8M -221.3M
Non operating interest income
Income 6.2M 3.9M 5.4M 4.7M
Expense 48.1M 37.6M 42.1M 29.8M
Other income expense -8.2M -14.4M -29.1M -19.8M
Pretax income -186.5M -181.7M -169.6M -266.2M
Tax provision -1.5M 2.1M
Net income -184.9M -183.8M -169.6M -267.4M
Basic EPS -1.0 -1.0 -0.9 -1.4
Diluted EPS -1.0 -1.0 -0.9 -1.4
Basic average shares 191.9M 190.5M 190.1M 189.4M
Diluted average shares 191.9M 190.5M 190.1M 189.4M
EBITDA -144.6M -148.9M -104.5M -227.8M
Net income from continuing op. -184.9M -183.8M -169.6M -267.4M
Minority interests 2.2M 1.9M 2.2M 2.3M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Post-market

Exchange is currently open for post-market.
Post market session closes in 1 hour 13 minutes

18:47
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).